Regulations Governing Reviewing Procedure of Drug Injury Review Committee of Ministry of Health and Welfare Article 3
Before the Review Committee reviewing an application of drug injury relief, it may send the applicant to two to four medical or pharmaceutical related professionals, or commission to domestic or international medical centers or academic institutions for preliminary review if necessary.The Review Committee starts reviewing an application by preliminary review by one to two medical or pharmaceutical related committee members, and then holds the Review Committee meeting. When reviewing a case, the opinion of preliminary review shall be considered, and mayAfter the review result being ratified by the competent authority, the Review Committee shall send the review result to the applicant.
中文原文 衛生福利部藥害救濟審議委員會審議辦法第3條
審議委員會審議藥害救濟申請案件,於審議前,如有必要,得先送請二至四位相關之醫學或藥學專家,或委請國內外醫學中心或學術機構進行初審。
審議委員會審議申請案件,由一至二位相關之醫學或藥學審議委員先行審查後,始召開審議會審議之。
案件經初審者,審議時應考量初審意見,並得請初審之專家列席說明。
審議委員會之審議結果,經主管機關核定後,函復申請人。
審議委員會審議申請案件,由一至二位相關之醫學或藥學審議委員先行審查後,始召開審議會審議之。
案件經初審者,審議時應考量初審意見,並得請初審之專家列席說明。
審議委員會之審議結果,經主管機關核定後,函復申請人。